KAS
FLNA

Kestra Advisory Services’s Filana Therapeutics FLNA Stock Holding History

Kestra Advisory Services’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-13,189
Closed -$388K – 2801
2024
Q3 		$388K Buy
13,189
+1,182
+10% +$27.2K ﹤0.01% 1928
2024
Q2 		$148K Buy
+12,007
New +$253K ﹤0.01% 2470
2023
Q1 		– Sell
-6,917
Closed -$204K – 2281
2022
Q4 		$204K Buy
+6,917
New +$249K ﹤0.01% 2012
2022
Q3 		– Sell
-34,997
Closed -$984K – 2223
2022
Q2 		$984K Buy
34,997
+26,625
+318% +$672K 0.01% 982
2022
Q1 		$311K Buy
8,372
+2,350
+39% +$99.6K ﹤0.01% 1573
2021
Q4 		$263K Sell
6,022
-3,215
-35% -$169K ﹤0.01% 1688
2021
Q3 		$573K Buy
9,237
+3,622
+65% +$302K 0.01% 1312
2021
Q2 		$480K Buy
5,615
+560
+11% +$30K 0.01% 1296
2021
Q1 		$227K Buy
+5,055
New +$199K ﹤0.01% 1649

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Kestra Advisory Services's FLNA Position: Q4 2024 in Review

Kestra Advisory Services sold out of Filana Therapeutics (FLNA) in Q4 2024, closing a stake of 13,189 shares — an estimated $388K sold.

Kestra Advisory Services first reported a position in FLNA in Q1 2021 and held it in 9 quarters. The position peaked at $984K in Q2 2022. 137 funds tracked by Wall St. Rank hold FLNA as of Q4 2024.

  • Kestra Advisory Services reported no remaining Filana Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Kestra Advisory Services sold 13,189 Filana Therapeutics shares in Q4 2024, an estimated $388K.
  • Kestra Advisory Services first reported a position in Filana Therapeutics in Q1 2021 and held it in 9 quarters.
  • Kestra Advisory Services's Filana Therapeutics position peaked at $984K in Q2 2022.
  • 137 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2024.

Based on Kestra Advisory Services's 13F filing for Q4 2024, filed 10 Feb 2025.